User login
- /content/daratumumab-regimen-shows-benefit-transplant-ineligible-myeloma
- /fedprac/article/201729/multiple-myeloma/daratumumab-regimen-shows-benefit-transplant-ineligible
- /hematologynews/article/201729/multiple-myeloma/daratumumab-regimen-shows-benefit-transplant
- /oncologypractice/article/201729/multiple-myeloma/daratumumab-regimen-shows-benefit-transplant
- /fedprac/avaho/article/201729/multiple-myeloma/daratumumab-regimen-shows-benefit-transplant
- /hematology-oncology/article/201729/multiple-myeloma/daratumumab-regimen-shows-benefit-transplant
- /hematologytimes/article/201729/multiple-myeloma/daratumumab-regimen-shows-benefit-transplant